Firstly, comorbidities (such as heart failure for anti-TNF antibodies and renal or hepatic failure for antibiotics) and frailty might affect treatment choice, constituting contraindications to or discouraging the use of immunomodulant drugs. Here, TNF is linked to liver failure.